Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of human breast cancer cell line MDA-MB-231 treated with T025 against untreated controls


ABSTRACT: Deep RNA sequencing was performed to investigate the impact of CLKs inhibitor, T-025, on RNA splicing in triple-negative breast cancer cell lines. A total of 30 million MDA-MB-231 cells were seeded in a 6-well plate. The following day, cells were treated with 1 µM T-025 or 0.1% DMSO as negative control for 24 hours. Samples from 3 biological replicates were used. Total RNA was isolated using the RNeasy plus mini kit (Qiagen). Stranded PolyA-selected libraries were prepared using the DNBseq platform, and 100 M 150-bp paired-end reads were sequenced on a DNBSEQ-G400 sequencer by BGI Europe. The differentially expressed genes (DEGs) and alternative splicing events (ASEs) were analyzed to unravel the transcriptomic changes in TNBC cells upon T-025 treatment.

INSTRUMENT(S): DNBSEQ-G400

ORGANISM(S): Homo sapiens

SUBMITTER: Jurjun Velde 

PROVIDER: E-MTAB-14664 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-12-31 | E-GEOD-56605 | biostudies-arrayexpress
2014-01-22 | E-GEOD-53354 | biostudies-arrayexpress
2014-05-12 | E-GEOD-54226 | biostudies-arrayexpress
2013-12-20 | E-GEOD-47431 | biostudies-arrayexpress
2014-05-14 | E-GEOD-57613 | biostudies-arrayexpress
2026-04-15 | E-MTAB-16857 | biostudies-arrayexpress
2011-02-03 | E-GEOD-17397 | biostudies-arrayexpress
2013-12-03 | E-GEOD-39937 | biostudies-arrayexpress
2014-06-11 | E-GEOD-58379 | biostudies-arrayexpress
2015-10-28 | E-GEOD-66737 | biostudies-arrayexpress